S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:SWAV

ShockWave Medical Stock Forecast, Price & News

$165.13
-7.40 (-4.29%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$161.39
$173.88
50-Day Range
$165.13
$241.83
52-Week Range
$88.07
$249.73
Volume
339,535 shs
Average Volume
364,038 shs
Market Capitalization
$5.83 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.25
30 days | 90 days | 365 days | Advanced Chart
Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for ShockWave Medical and its competitors with MarketBeat's FREE daily newsletter.


ShockWave Medical logo

About ShockWave Medical

Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton on June 17, 2009 and is headquartered in Santa Clara, CA.

Headlines

Relative Strength Alert For ShockWave Medical
December 1, 2021 |  nasdaq.com
Shockwave Medical (SWAV) Gains 0.6% Post Q3 Earnings Beat
November 11, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
2,019
Year Founded
N/A

Sales & Book Value

Annual Sales
$67.79 million
Book Value
$6.24 per share

Profitability

Net Income
$-65.70 million
Pretax Margin
-21.49%

Debt

Price-To-Earnings

Miscellaneous

Free Float
29,902,000
Market Cap
$5.83 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/08/2021
Today
12/05/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/16/2022

MarketRank

Overall MarketRank

2.29 out of 5 stars

Medical Sector

302nd out of 1,388 stocks

Surgical & Medical Instruments Industry

30th out of 126 stocks

Analyst Opinion: 3.2Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 0.6 5 -4 -3 -2 -1 -












ShockWave Medical (NASDAQ:SWAV) Frequently Asked Questions

Is ShockWave Medical a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ShockWave Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SWAV, but not buy additional shares or sell existing shares.
View analyst ratings for ShockWave Medical
or view top-rated stocks.

How has ShockWave Medical's stock been impacted by Coronavirus?

ShockWave Medical's stock was trading at $34.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SWAV stock has increased by 379.5% and is now trading at $165.13.
View which stocks have been most impacted by COVID-19
.

When is ShockWave Medical's next earnings date?

ShockWave Medical is scheduled to release its next quarterly earnings announcement on Wednesday, February 16th 2022.
View our earnings forecast for ShockWave Medical
.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) released its earnings results on Monday, November, 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.12. The company had revenue of $65.16 million for the quarter, compared to the consensus estimate of $61.21 million. ShockWave Medical had a negative trailing twelve-month return on equity of 17.68% and a negative net margin of 21.60%. The company's quarterly revenue was up 232.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.38) earnings per share.
View ShockWave Medical's earnings history
.

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical issued an update on its FY 2021 earnings guidance on Monday, November, 29th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $227 million-$228 million, compared to the consensus revenue estimate of $223.43 million.

What price target have analysts set for SWAV?

7 equities research analysts have issued 12-month price objectives for ShockWave Medical's stock. Their forecasts range from $200.00 to $272.00. On average, they expect ShockWave Medical's share price to reach $238.33 in the next twelve months. This suggests a possible upside of 44.3% from the stock's current price.
View analysts' price targets for ShockWave Medical
or view top-rated stocks among Wall Street analysts.

Who are ShockWave Medical's key executives?

ShockWave Medical's management team includes the following people:
  • Douglas Evan Godshall, President, Chief Executive Officer & Director (LinkedIn Profile)
  • Mike Maszy, Vice President-Operations
  • Daniel Puckett, Chief Financial officer & Secretary
  • Beaux Alexander, Vice President-Clinical Affairs
  • W. Patrick Stephens, Vice President-Research & Development

What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical CEO Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among ShockWave Medical's employees.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Square (SQ), Trade Desk (TTD), salesforce.com (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are ShockWave Medical's major shareholders?

ShockWave Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.32%), Invesco Ltd. (3.71%), Artisan Partners Limited Partnership (2.39%), Credit Suisse AG (1.71%), Geode Capital Management LLC (1.70%) and Lord Abbett & CO. LLC (1.69%). Company insiders that own ShockWave Medical stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis and Sofinnova Capital Vii Fcpr.
View institutional ownership trends for ShockWave Medical
.

Which institutional investors are selling ShockWave Medical stock?

SWAV stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Credit Suisse AG, Barclays PLC, Macquarie Group Ltd., Bellevue Group AG, Caption Management LLC, Renaissance Technologies LLC, and Artisan Partners Limited Partnership. Company insiders that have sold ShockWave Medical company stock in the last year include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, and Laura Francis.
View insider buying and selling activity for ShockWave Medical
or view top insider-selling stocks.

Which institutional investors are buying ShockWave Medical stock?

SWAV stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Morgan Stanley, CastleArk Alternatives LLC, Ziegler Capital Management LLC, Pura Vida Investments LLC, Balyasny Asset Management LLC, Balyasny Asset Management LLC, and Penserra Capital Management LLC.
View insider buying and selling activity for ShockWave Medical
or or view top insider-buying stocks.

How do I buy shares of ShockWave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $165.13.

How much money does ShockWave Medical make?

ShockWave Medical has a market capitalization of $5.83 billion and generates $67.79 million in revenue each year. The company earns $-65.70 million in net income (profit) each year or ($1.10) on an earnings per share basis.

How many employees does ShockWave Medical have?

ShockWave Medical employs 2,019 workers across the globe.

What is ShockWave Medical's official website?

The official website for ShockWave Medical is www.shockwavemedical.com.

Where are ShockWave Medical's headquarters?

ShockWave Medical is headquartered at 5403 Betsy Ross Drive, Santa Clara CA, 95054.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at (510) 279-4262 or via email at [email protected].


This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.